Injection of e.g. viscoelastic gel into the vitreous cavity

PheWeb

DM_EYE_OPER_INJECT_GEL_VITR

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions

DIABETES_FG

55191

Filter registries

Operations: NOMESCO codes ^CKD15

168

Check pre-conditions, main-only, mode, ICD version None

168

Check minimum number of events None

168

Include endpoints None

168

DM_EYE_OPER_INJECT_GEL_VITR

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Injection of e.g. viscoelastic gel into the vitreous cavity based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	165	65	100
Unadjusted prevalence (%)	0.05	0.04	0.07
Mean age at first event (years)	50.73	46.99	53.16

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: DM_EYE_OPER_INJECT_GEL_VITR – Injection of e.g. viscoelastic gel into the vitreous cavity
GWS hits:

Survival analyses between endpoints

↥

Plot

before Injection of e.g. viscoelastic gel into the vitreous cavity
after Injection of e.g. viscoelastic gel into the vitreous cavity

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Injection of e.g. viscoelastic gel into the vitreous cavity

↥